Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

PhRMA Launches New Ad Campaign to Improve Biopharma’s Image

XTALKS VITALS NEWS

Advertising

The ads will be featured on multiple media streams – including TV, print and digital – in an effort to repair the industry’s tarnished reputation after highly-publicized enquiries into drug price hikes.

Share this!

January 26, 2017 | by Sarah Hand, M.Sc.

Pharmaceutical industry trade group, PhRMA, has unveiled a new multimillion-dollar ad campaign named GoBoldly. The ads will be featured on multiple media streams – including TV, print and digital – in an effort to repair the industry’s tarnished reputation after highly-publicized enquiries into drug price hikes.

“Thanks to the tireless work of biopharmaceutical researchers and scientists, we have entered a new era of medicine that is transforming the way we prevent and treat disease,” said Stephen J. Ubl, president and chief executive officer of PhRMA. “This campaign spotlights their perseverance and unwavering commitment to American patients for whom we all work. We will also be convening events with stakeholders all across the country to discuss ways we can work together to make our health care system more responsive to the needs of patients.”

The first GoBoldy ad – “Do Not Go Gentle” – features video of scientists at work compiled with images of cells and blood flowing through vessels. The ad also includes Dylan Thomas’ poem of the same name being read aloud over the images and video.



In response to an ad campaign Ubl is calling, “less hoodie, more lab coats,” ex-pharma CEO Martin Shkreli created a website aimed at airing some of the industry’s dirty laundry. Pharmaskeletons.com names 26 pharma companies and how they’ve negatively contributed to the current state of drug pricing in the US.

In a few weeks, the trade organization will release their next ad – “Cells” – which reportedly shows video of a cancer cell self-destructing. The new ad campaign sends a stronger message compared to PhRMA’s previous emotionally-driven “From Hope to Cures” campaign.

However, this new attempt by the industry to improve public relations makes no mention of changing the pricing practices which have become such a hot-button issue in the industry today. Instead the multiyear campaign will focus on the most exciting new advancements in science and medicine, value-driven healthcare and public health matters.


Keywords: Advertising, Biopharma, Pharmaceutical Industry


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Better Meal Planning for Diabetics Using a Predictive Blood Sugar App

April 21, 2017 - A new app could allow people with type 2 diabetes to make predictions about the impact of a meal on their blood sugar levels, before they even take a bite.

Featured In: Life Science News


Bacterial Biomarkers Could Make Diagnosing Colorectal Cancer Less Invasive

April 20, 2017 - Researchers at The University of Texas Health Science Center at Houston School of Public Health have identified specific strains of gut bacteria which have been associated with colorectal cancer.

Featured In: Life Science News


Weetabix Cereal Sold to Post in £1.4 Billion Deal

April 20, 2017 - The cereal was sold by Shanghai-based Bright Food, which acquired a controlling stake in the company in 2012.

Featured In: Food News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

What Medical Device Manufacturers Need to Know Before Developing a Biological Safety Evaluation

REGISTER FOR THESE WEBINARS

Electronic Informed Consent: 2017 Industry Survey Results


Critical CRO Oversight Metrics: How to Establish the Right Metrics and Monitor them in Real-Time


The Modernization of eCOA Technology for Clinical Trials


Developing a Biological Safety Evaluation


Copyright © 2016-2017 Honeycomb Worldwide Inc.